NHS Accelerated Access Collaborative

Delivering the best health innovations to patients faster than ever.

We’re bringing together industry, government, regulators, patients and the NHS to remove barriers and accelerate the introduction of ground-breaking new treatments and diagnostics which can transform care.

The AAC supports all types of innovations: medicines, diagnostics, devices, digital products, pathway changes and new workforce models.

Matt Whitty, Chief Executive Accelerated Access Collaborative

Matt Whitty, Director of Innovation, Research and Life Sciences, and Chief Executive of the Accelerated Access Collaborative (AAC) introduces the AAC’s Our Year in focus 2019/20 report.

The report provides a summary of the AAC’s achievements in 2019/20. Highlighting how over 700,000 patients have been provided with access to proven health and care  innovations supported by the AAC, resulting in estimated patient benefits of over 12,000 fewer hospital admissions and 125,000 fewer days spent in hospital. Across the AAC programmes this work has saved the NHS over £50million.


Developing a shared view: Enabling innovation and adoption in health and social care

Innovation has been central during the global COVID-19 pandemic in finding solutions to complex and urgent challenges. As a way of supporting innovation, the Accelerated Access Collaborative (AAC) and the Care Quality Commission (CQC) have worked in partnership with providers and stakeholders to develop a set of 6 evidence-based principles that are crucial for providers […]